Acute chest pain (ACP) is a common symptom that often leads to hospital admission. It is a challenge for healthcare professionals due to its broad differential diagnosis, ranging from benign conditions to life-threatening diseases such as acute coronary syndrome (ACS).
Each encounter with a patient presenting ACP should begin with a thorough history and physical examination. The patient's age, sex, risk factors for cardiovascular disease, and the characteristics of the pain should guide the initial assessment. A detailed history can help distinguish cardiac from non-cardiac causes.
Electrocardiogram (ECG) is the first-line diagnostic test in ACP. It can identify ST-segment elevation myocardial infarction (STEMI), which requires immediate reperfusion therapy. In non-diagnostic ECGs, high-sensitivity cardiac troponin (hs-cTn) assays are critical for the early detection of non-ST elevation ACS.
Risk stratification is crucial in ACP. Several risk scores, such as the GRACE and TIMI scores, can predict the likelihood of adverse outcomes in ACS. These scores can guide the decision for invasive management. For low-risk patients, coronary CT angiography can rule out significant coronary artery disease.
Management of ACP depends on the underlying cause. In ACS, early reperfusion therapy in STEMI or optimal medical therapy in non-ST elevation ACS is recommended. Non-cardiac causes of ACP should be managed accordingly. It is essential to reassess the patient's response to treatment and adjust the management plan as necessary.
In conclusion, the approach to ACP involves a systematic evaluation, appropriate diagnostic testing, risk stratification, and tailored management strategies. A high index of suspicion and a comprehensive understanding of the various causes of ACP are crucial for healthcare professionals to provide the best patient care.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation